Viewing Study NCT00995761


Ignite Creation Date: 2025-12-24 @ 11:48 AM
Ignite Modification Date: 2026-01-31 @ 6:04 PM
Study NCT ID: NCT00995761
Status: COMPLETED
Last Update Posted: 2014-03-03
First Post: 2009-10-14
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Biweekly Schedule of Docetaxel and Cisplatin in High Risk Patients With Unresectable Non-small Cell Lung Cancer (NSCLC)
Sponsor: Gyeongsang National University Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-small Cell Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None biweekly View
None docetaxel View
None cisplatin View
None non-small cell lung cancer View